Filing Details
Immix Biopharma, Inc. (NASDAQ:IMMX) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event.
8k filedNASDAQ:IMMX
Immix Biopharma, Inc. (IMMX) Reports Material Event to SEC
Filing Details Immix Biopharma, Inc. (NASDAQ:IMMX) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market Context Immix…
Market Context
Immix Biopharma, Inc.'s stock currently trades at $8.80 with a market capitalization of $246.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Immix Biopharma, Inc.'s stock.
All SEC filings for Immix Biopharma, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IMMX Stock Page
Frequently Asked Questions
Where can I read IMMX's SEC filings?
Browse all filings on our IMMX SEC filings page.
What types of SEC filings does Immix Biopharma, Inc. file?
Public companies like Immix Biopharma, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.